BYHEALTH CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.96 CNY | -0.73% |
|
-1.06% | -12.16% |
| Apr. 25 | Byhealth Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 12 | Byhealth Co., Ltd Approves Cash Dividend for the Year 2023 | CI |
ETFs positioned on Byhealth Co., Ltd
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.05% | 11 M€ | +4.09% | ||
| 0.04% | 4 M€ | -11.56% | ||
| 0.04% | 3 M€ | +2.31% | - | |
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 454 M€ | +5.58% | - | |
| 0.00% | 2,867 M€ | +8.16% | - | |
| 0.00% | 153 M€ | +5.53% | - | |
| 0.00% | 112 M€ | +5.18% | - | |
| 0.00% | 32 M€ | +7.35% | - | |
| 0.00% | 391 M€ | +9.70% | - | |
| 0.00% | 34 M€ | +9.03% | - | |
| 0.00% | 39 M€ | +6.40% | - | |
| 0.00% | 306 M€ | +6.81% | - | |
| 0.00% | 34 M€ | +4.32% | - | |
| 0.00% | 105 M€ | +4.45% | - | |
| 0.00% | 17 M€ | +3.59% | - | |
| 0.00% | 7 M€ | +6.05% | - | |
| 0.00% | 54 M€ | +1.35% | - | |
| 0.00% | 8 M€ | +1.40% | - | |
| 0.00% | 15 M€ | +16.35% |
Byhealth Co Ltd is a China-based company mainly engaged in the research, development, production and sales of dietary nutritional supplements. The Company's main products include glucosamine chondroitin vitamin D calcium tablets, natto red yeast and ginkgo leaf capsules, pueraria curcuma collagen tablets, donkey-hide gelatin angelica astragalus tablets, fish oil soft capsules, glucosamine chondroitin sulfate collagen peptide tablets and glucosamine chondroitin sulfate calcium tablets. The Company's main product categories include immune-boosting products, women's health products, bone health products and vitamins. The Company's products are mainly sold online and offline through brands such as By-Health, Jianliduo and Lifespace. The Company mainly conducts its businesses in domestic and overseas markets.
Sector
Food Processing
Calendar
2024-08-04
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
D
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
14.96
CNY
Average target price
22.19
CNY
Spread / Average Target
+48.34%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -12.16% | 3.51B | |
| +11.97% | 8.05B | |
| +8.98% | 7.96B | |
| +3.48% | 6.12B | |
| -5.68% | 3.73B | |
| -13.23% | 1.19B | |
| -26.34% | 1.12B | |
| +13.13% | 975M | |
| -8.84% | 931M | |
| -13.68% | 828M |
- Stock Market
- Equities
- 300146 Stock
- Funds and ETFs Byhealth Co., Ltd
